Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-450
Closed -$27K 3770
2019
Q3
$27K Buy
450
+3
+0.7% +$206 ﹤0.01% 3683
2019
Q2
$31K Buy
+447
New +$26.7K ﹤0.01% 3699
2019
Q1
Sell
-1,446
Closed -$85K 3771
2018
Q4
$85K Buy
+1,446
New +$97.6K ﹤0.01% 3545
2018
Q2
Sell
-668
Closed -$44K 3702
2018
Q1
$44K Sell
668
-309
-32% -$25.9K ﹤0.01% 3593
2017
Q4
$94K Buy
+977
New +$95.5K ﹤0.01% 3564
2016
Q1
Sell
-617
Closed -$51K 3871
2015
Q4
$51K Sell
617
-298
-33% -$26.9K ﹤0.01% 3789
2015
Q3
$94K Buy
+915
New +$114K ﹤0.01% 3732
2014
Q4
Sell
-26
Closed -$5K 4397
2014
Q3
$5K Sell
26
-2
-7% -$420 ﹤0.01% 5145
2014
Q2
$6K Buy
28
+9
+47% +$1.9K ﹤0.01% 4897
2014
Q1
$4K Sell
19
-20
-51% -$5.14K ﹤0.01% 4856
2013
Q4
$13K Buy
39
+7
+22% +$2.24K ﹤0.01% 4264
2013
Q3
$9K Hold
32
﹤0.01% 4982
2013
Q2
$8K Buy
+32
New +$8.72K ﹤0.01% 4941

Other funds holding VEON

Ameriprise's VEON Position: Q4 2019 in Review

Ameriprise sold out of VEON (VEON) in Q4 2019, closing a stake of 450 shares — an estimated $27K sold.

Ameriprise first reported a position in VEON in Q2 2013 and held it in 13 quarters. The position peaked at $94K in Q4 2017. 125 funds tracked by Wall St. Rank hold VEON as of Q4 2019.

  • Ameriprise reported no remaining VEON position as of Q4 2019 after selling out during the quarter.
  • Ameriprise sold 450 VEON shares in Q4 2019, an estimated $27K.
  • Ameriprise first reported a position in VEON in Q2 2013 and held it in 13 quarters.
  • Ameriprise's VEON position peaked at $94K in Q4 2017.
  • 125 funds tracked by Wall St. Rank held VEON as of Q4 2019.

Based on Ameriprise's 13F filing for Q4 2019, filed 14 Feb 2020.